Press release
Beyfortus Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis
The Beyfortus Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].What Is the Current Beyfortus Market Size and Its Estimated Growth Rate?
In recent times, the beyfortus market has seen an XX (HCAGR) enlargement in its size. The market is projected to expand from a value of $XX million in 2024 to $XX million in 2025, progressing at a compound annual growth rate (CAGR) of XX%. The significant development during the historic phase is due to the escalating requirements for efficient newborn preventative treatments, heightened demand for long-lasting monoclonal antibodies, amplified global cognizance of respiratory ailments, geographic proliferation, and an increased emphasis on infant wellbeing.
The market size for beyfortus is projected to witness a growth of XX (FCAGR) in the forTH*Coming years, hitting a projected worth of $XX million in 2029 with a compound annual growth rate (CAGR) of XX%. This growth within the forecast period is likely due to the rising instances of respiratory syncytial virus (RSV) infections, an increased medical demand for RSV prevention, growing attention from healTH*Care providers, the mounting influence of health policy, and the expanding diversity in clinical trials. Key trends occurring during the forecast period include AI's application in drug development, telemedicine and remote monitoring, regenerative medicine, the advent of wearable technologies and biosensors, and advancements in gene editing via CRISPR technology.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19999
How Are Emerging Segments Shaping the Beyfortus Market Landscape?
The beyfortus market covered in this report is segmented -
1) By Indication: Respiratory Syncytial Virus (RSV) Prevention, Infant Care
2) By Age Group: Infants And Neonates, Children, Elderly Population
3) By Distribution Channel: Hospitals, Pharmacies, Public Health Programs
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19999&type=smp
Which Growth Factors Are Influencing Beyfortus Market Expansion?
The escalation in the number of Respiratory Syncytial Virus (RSV) cases is predicted to fuel the expansion of the Beyfortus market. RSV, which is highly infectious, primarily affects the respiratory tract, leading to diseases like bronchiolitis and pneumonia. It is particularly prevalent among infants, young children, seniors, and those with compromised immune systems. The rise in RSV instances is attributed to late exposure due to pandemic restrictions, changing virus seasonality, diminished immunity in children, and enhanced social engagements. Beyfortus aids in curtailing RSV instances by offering passive immunity via a single-dose monoclonal antibody, nirsevimab, which targets and neutralizes the Respiratory Syncytial Virus, thereby warding off severe lower respiratory tract infections in newborns and infants during their initial RSV season. For example, the National Library of Medicine, a US-based medical library, reported in June 2024, that between 2021 and 2023, there was a 2.4 times increase in RSV patients (95% confidence interval [CI]: 1.7, 3.5) as compared to the pre-pandemic era. Additionally, RSV test volume witnessed a surge by 18.9-fold (95% CI: 15.0, 23.9). Thus, the rising incidence of RSV cases pushes the growth of the Beyfortus market.
Who Are the Dominant Players Across Different Beyfortus Market Segments?
Major companies operating in the beyfortus market include AstraZeneca plc; Sanofi SA
What Are the Latest Developing Trends in the Adcetris Market?
The primary trend in the beyfortus market is the focus on the creation of ground-breaking medications, such as human IgG1? antibodies, offering high stability, efficient binding to antigens, and robust immune response activation. Human IgG1? antibody is a IgG immunoglobulin class subtype, notable for its specificity in structure and function in immune responses, particularly its capacity to bind to antigens and activate immune cells. For example, in July 2023, Sanofi SA, a health care company headquartered in France, in collaboration with AstraZeneca Plc, a UK-based pharmaceutical and biotech firm, declared the FDA-approved Beyfortus (nirsevimab-alip). It is prescribed for the prevention of lower respiratory tract disease (LRTD), a result of the respiratory syncytial virus (RSV), in neonates and infants during their first RSV season and also in children up to 24 months old with a continued risk of severe RSV disease during their second RSV season. Beyfortus' FDA approval followed a positive endorsement from the FDA Antimicrobial Drugs Advisory Committee and comes with the backing of a comprehensive clinical development program, inclusive of three crucial late-stage trials. In these tests, Beyfortus, with just a single dose, demonstrated a high and steadfast efficacy against RSV LRTD, offering protection for up to five months, typically the duration of an RSV season. Furthermore, Beyfortus featured an agreeable tolerance, with a consistently favorable safety profile across all clinical research studies.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/beyfortus-global-market-report
Which Geographic Regions Are Expected to Dominate the Beyfortus Market in the Coming Years?
North America was the largest region in the beyfortus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the beyfortus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Beyfortus Market?
2. What is the CAGR expected in the Beyfortus Market?
3. What Are the Key Innovations Transforming the Beyfortus Industry?
4. Which Region Is Leading the Beyfortus Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Beyfortus Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis here
News-ID: 4064062 • Views: …
More Releases from The Business Research Company
Global Semantic Knowledge Graphing Market Projected to Grow at 12.5% CAGR, Reach …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Semantic Knowledge Graphing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been significant growth in the market size of semantic knowledge graphing. It is anticipated that the market will expand from $1.49 billion in 2024 to $1.7 billion in 2025,…
Global Security Analytics Industry Outlook 2025-2029: Market Set to Cross $35.7 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Security Analytics Market Through 2025?
The market size for security analytics has rapidly expanded in the recent past. From $17 billion in 2024, it is projected to swell up to $19.74 billion in 2025, representing a compound annual growth rate (CAGR) of…
Remote Work Revolution Fueling The Surge In Robotic Process Automation (RPA) Tec …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Robotic Process Automation (RPA) In Information Technology Industry Market Size Be by 2025?
The market size of Robotic Process Automation (RPA) in Information Technology has seen an explosive growth recently. The market is projected to expand from $1.42 billion in 2024 to $1.78 billion in 2025,…
Soaring Demand Set to Propel Remote Firmware Market to $13.58 Billion by 2029
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Remote Firmware Market Size By 2025?
The market size of remote firmware has experienced substantial growth in the past few years. It is projected to increase from $7.35 billion in 2024 to $8.37 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%.…
More Releases for Beyfortus
Respiratory Syncytial Virus (RSV) Prophylaxis Market to Reach $11.3 Billion by 2 …
Introduction
Respiratory Syncytial Virus (RSV) remains one of the most common causes of lower respiratory tract infections globally, particularly affecting infants, young children, and the elderly. Long recognized as a seasonal public health challenge, RSV infections lead to significant hospitalizations, especially in vulnerable populations. Recent advances in vaccine and monoclonal antibody development have ushered in a transformative phase for RSV prevention and management.
According to Exactitude Consultancy, the Global RSV Prophylaxis Market…
Respiratory syncytial virus Market Analysis: Epidemiology Insights, Therapies, C …
According to DelveInsight's patient-based forecasting model, the total Respiratory Syncytial Virus Market Size in the 7MM was around USD 1,300 million in 2023.
Emerging therapies for respiratory syncytial virus (RSV), including ABRYSVO (RSVpreF), BEYFORTUS (nirsevimab), mRNA-1345, VAC 18193 (Ad26.RSV.preF), and others, are expected to drive growth in the RSV market in the coming years.
DelveInsight has released a new report titled "Respiratory Syncytial Virus - Market Insights, Epidemiology, and Market Forecast-2034", offering…
Respiratory Syncytial Virus Prevention Market Accelerates on FDA Approvals and N …
DelveInsight's comprehensive Respiratory Syncytial Virus (RSV) market report shows USD 1,300M market size in 2023 with 8.6M incident cases across 7MM. Key players Pfizer (ABRYSVO), GSK (AREXVY), Sanofi/AstraZeneca (BEYFORTUS), Moderna (mRNA-1345), Janssen (VAC 18193) driving transformation from supportive care to preventive treatments through breakthrough vaccines and monoclonal antibodies, revolutionizing RSV prevention landscape.
Respiratory Syncytial Virus Key Takeaways
*
Respiratory Syncytial Virus Market size projection: As per DelveInsight's analysis, the total market size…
Expanding the Preventive Care Frontier: Dr. Reddy's Launches Sanofi's Beyfortus …
In a significant advancement for infant healthcare in India, Dr. Reddy's Laboratories (NYSE: RDY) (NSE: DRREDDY) has officially launched Beyfortus Registered (nirsevimab), a novel preventive treatment for Respiratory Syncytial Virus (RSV) in infants. This launch follows the April 2025 announcement of their expanded partnership with Sanofi Healthcare India Private Limited that granted Dr. Reddy's exclusive rights to promote and distribute the drug in India.
Addressing an Underreported Health Crisis
According to paediatric…
Respiratory syncytial virus Market: Epidemiology, Therapies, Companies, DelveIns …
Respiratory syncytial virus therapies, such as ABRYSVO (RSVpreF), BEYFORTUS (nirsevimab), mRNA-1345, VAC 18193 (Ad26.RSV.preF), and others, are expected to boost the Respiratory syncytial virus Market in the upcoming years.
DelveInsight has launched a new report on "Respiratory syncytial virus - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Respiratory syncytial virus, historical and forecasted epidemiology as well as the Respiratory syncytial virus market trends in the…
Rising RSV Cases Driving Market Growth For Beyfortus: A Key Factor Shaping the F …
Which drivers are expected to have the greatest impact on the over the beyfortus market's growth?
The surge in cases of Respiratory syncytial virus (RSV) is anticipated to boost the expansion of the beyfortus market. RSV is an extremely transmissible virus that primarily affects the respiratory system, leading to diseases like bronchiolitis and pneumonia, more prevalent in infants, young kids, seniors, and immunocompromised people. The rise in RSV cases is due…
